Deliver new therapies, faster and smarter, with the patient-powered Xperiome platform
Get in front of research-activated populations, leveraging the Xperiome platform to create truly patient-centric drug development and commercialization programs.
The Xperiome platform’s technology drives a novel engagement engine built on behavioral-science principles. It is designed to find and engage hard-to-reach patient populations and retain them in studies over long periods of time.
The missing puzzle piece for pharma is often the patient. Leverage the Xperiome platform throughout drug development and commercialization to connect with the right patients, complete your datasets, and deliver superior health outcomes.
Develop novel molecules
Design robust trial protocols fit for the new normal, including decentralized and hybrid models, with meaningful patient input. Engage, recruit and retain hard-to-reach patients in clinical studies globally, in line with the highest ethical standards. Leverage the Xperiome platform to expedite your route to regulatory success.
Launch new medicines
Bolster your go-to-market strategy with the compelling real-world data expected by regulators. Demonstrate to payers the true value of your medicines with the power of the patient voice. Conduct quantitative and qualitative research studies using the Xperiome platform, and craft impactful awareness campaigns for patients and healthcare professionals.
Expand your market
Capture data on patient satisfaction with new medicines, longitudinally and across international markets. Evaluate the effectiveness of new treatments – globally and in new indications – in the real-world setting. Succeed in an increasingly challenging reimbursement landscape with the Xperiome platform’s patient-experience data.